Biomarkers of Response to Ketamine in Depression: MRI and Blood Assays Before and After Open Label Intranasal Ketamine

NCT04216888 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Depressive Disorder, Treatment-Resistant

Interventions

DRUG: Ketamine Hydrochloride

Sponsor

Dan Iosifescu